NCT04068597 2025-12-18Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesCellCentric Ltd.Phase 1/2 Recruiting250 enrolled
NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts